|Articles|January 10, 2017
Profil Institute Becomes ProSciento, Inc.
Profil Institute for Clinical Research, Inc. has announced the launch of its new corporate name, ProSciento Inc.
Advertisement
Profil Institute for Clinical Research, Inc. has announced the launch of its new corporate name, ProSciento Inc. Under a broader rebranding campaign, the name change represents the company’s focus on metabolism clinical R&D for diabetes, obesity and NAFLD/NASH.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
2
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
3
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
4
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
5